Daniel J. O'Connor
CIK 1376847 · President and CEO · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
8
Total Filings
87
Lifetime Open-Market Net
-$845.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMAC | Director | 0 | $5.65 | $0 | $0 | 2 | 2026-06-03 |
| Ambrx Biopharma, Inc. (AMAM) Delisted | President and CEO | 0 | $28.00 | $0 | -$491.1K | 5 | 2024-03-07 |
| SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Director | 16,000 | $0.39 | $6.2K | $9.8K | 7 | 2024-01-08 |
| ZyVersa Therapeutics, Inc. (LSPRW) Delisted | Chief Executive Officer | 42,005 | $0.18 | $7.6K | $0 | 1 | 2022-03-10 |
| ONCOSEC MEDICAL Inc (ONCS) Delisted | CEO and President | 96,097 | $0.28 | $26.6K | -$48.5K | 18 | 2021-05-04 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Chief Executive Officer | 618,352 | — | — | -$68.6K | 11 | 2017-07-03 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Executive Officer | 302,710 | — | — | -$247.4K | 39 | 2016-10-04 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | SVP, Interim Gen. Counsel, Sec | — | — | — | $0 | 2 | 2007-02-21 |
Recent Filings · Page 8 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-02 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +1,267 | $4.9K | EDGAR |
| 2014-08-01 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | −5,398 | -$24.6K | EDGAR |
| 2014-07-18 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Tax (F) | −16,468 | -$66.4K | EDGAR |
| 2014-07-01 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +2,770 | -$3.8K | EDGAR |
| 2014-02-04 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +1,536 | -$2.5K | EDGAR |
| 2014-01-09 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +231,840 | -$73.2K | EDGAR |
| 2014-01-09 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +6,752 | -$16.4K | EDGAR |
| 2014-01-03 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +7,485 | $27.7K | EDGAR |
| 2013-11-12 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +1,263 | $5.6K | EDGAR |
| 2013-11-12 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +4,138 | $18.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.